Global Tumor Ablation Devices Market Size was valued nearly USD 421 million by 2018 and is estimated to reach up to USD xx.xx billion by 2025. According to latest study conducted by our analysts and industry experts, the global market is expected to grow at a CAGR of 11.21% during the forecast period that is 2017-2025. Asia Pacific held the largest share of the global market in 2018 and will expand at the highest CAGR during the forecast years.  

Global Market Growth Opportunities (Revenue, Growth) By 2017-2025   

Tumor ablation devices such as radiofrequency, microwave, chemical and others are used for treating liver, lung, kidney, prostate and others cancer cells. These therapies will help to provide relief from tumor below 3cm. The treatment with tumor ablation devices facilitates less pain and takes shorter time in recovery than conventional surgical procedures. Moreover, it has lower side effects and lower downs the damages of soft tissues surrounding the tumor cells during the treatment. Therefore, the market is anticipated to grow significantly over the projected period owing to rising cancer cases coupled with the evolvement of technology such as high intensity focused ultrasound technology used for treatment.

Tumor Ablation is a surgical procedure with minimum invasion to treat solid cancer cells.  The minimum invasion surgical procedure uses special probes to freeze and burn the cancer cells. The position of the probe within the tumor is guided by ultrasound, computed tomography (CT) or magnetic resonance imaging. A tiny hole is made in the body to inject the probe in the affected area, which is further attached to the generator that freezes or burns the cancer cells.

Market Dynamics

The market is majorly driven by the development of the advanced ablation technology for the tumor treatment. For instance, irreversible electroporation and microwave ablation are considered to be newer technology in the market considered for the treatment of lung and liver cancers. Numerous animal studies have been facilitated with both type ablation technology. However, there is no defined device settings are available for both the ablation technologies. The other sprouting technologies include high intensity focused ultrasound and stereotactic body radiation.

Segment Analysis

Technology Insights: Radiofrequency ablation technology is anticipated to dominate the market over the projected period, owing to the rising lung and liver cancer, due to rise in tobacco and alcohol consumption. According to the World Health Organization, the estimated number of cases and deaths of lung cancer by the end of 2018 accounts for approximately 2.09 million cases and 1.76 million deaths, respectively.

Furthermore, the microwave ablation technology is expected to have substantial growth during the forecast period, attributed to the various benefits being offered. As, reduces the procedural pain, decreases the destruction of soft tissue surrounding the tumor coupled with the faster heat generation and thus, reduces the probability to damage the associated organs in the body.

Application Insights: Lung cancer treatment using ablation technology is perceived to hold one of the key application area followed by liver cancer in the global tumor ablation market over the forecast period, owing to rising number of lung and liver cancer patients across the globe thereby resulting in development of newer technology such as microwave ablation technology. Owing to which there is increase in the adoption microwave ablation technology by healthcare professionals. For instance, University of California San Francisco is one of the cancer centers which offers microwave ablation for the treatment of liver cancers such as primary liver cancer including hepatocellular carcinoma which is associated with hepatitis B and C and cirrhosis. The university also treats secondary liver cancer using microwave ablation such as metastatic.

Regional Insights

The global tumor ablation devices market is divided into regions that are North America - U.S, Canada, Other; Asia-Pacific -India, Japan, China, Australia, Other; Europe - UK, Russia, France, Brazil, Other; Middle East and Africa. Every region analysis details in sense of growth, revenue, volume, challenges, and opportunities with the regional and global key players. North America is anticipated to account major share in the global market, particularly the U.S., followed by Europe owing to the increasing replacements of the conventional ablation technology with the newer ablation technology for the treatment of tumors. For instance, EDAP TMS developed high intensity focused ultrasonic systems in 2016. It is a robotic device that facilitates the ablation of prostate tumor. This novel ablation device is available in numerous institutes such as University of Miami, the Cleveland Clinic, USC in Los Angeles (LA) and others for contributing in the awareness of the ablation device in the U.S. Middle East and Africa held the measurable growth in the global market in 2018 and will expand at the significant CAGR during the forecast years.    

Global Tumor Ablation Devices Market Size, Share Analysis By Region 2017

Global Tumor Ablation Devices Market Study Objective

1. To forecast the market size of tumor ablation devices market, along with describing and defining the market, in terms of volume and revenue as well as market opportunities for stakeholders, in order to provide a competitive landscape for global market players.

2. Market analysis and forecast of tumor ablation devices market on the basis of region, substrate and application or end-use industry. To profile major market players, and to analyze their market shares and essential competencies comprehensively.

3. To analyze and elaborate significant factors that will have major impact on the growth of tumor ablation devices market, such as drivers, restraints, challenges and opportunities.

4. Regional analysis of tumor ablation devices market, to induce market size of five global major regions, which include, Europe, North America, South America, Middle East & Africa and Asia Pacific.

5. Strategic analysis of micromarkets, in terms of individual prospects, opportunities, growth trends and their involvement in overall market.

6. To provide detailed analysis of competitive and strategic developments in the tumor ablation devices market like new product launch, partnership & agreement, investment & expansion, and company merger & acquisitions.

Competitive Landscape

Key players operating in the market includes Medtronic Plc, SonaCare Medical, LLC, Johnson & Johnson, Intuitive Surgical, Galil Medical Inc., Alpinion Medical Systems Co.,Ltd., Smith & Nephew Plc, Abbott Laboratories, Boston Scientific Corporation and several Others. Mergers& Acquisitions, product launch and development., partnership & collaborations are the key undertakings of the companies to show the market presence. For instance, NeuWave medical Inc., a leading manufacturer of microwave ablation devices was acquired by the Ethicon, a Johnson &Johnson company in 2016 to increase its product portfolio in tumor ablation devices.

Global Tumor Ablation Devices Market Study Report Offer You!

The global market study report gives an idea about market size, share, stock, equity, investment and total price analysis. Also, the report provides comprehensively industry insights with all major factors such as market credit, allocation, demand, distribution, market scope, key players, end user & applications, provisions, livestock, commodities and industry economics analysis, future growth & forecast. The global market report includes all depth data like pre-market emphasis, market survey, market investment, industry advice, portfolio, finance, access, trade, market exploration, industry review and market predication & projection to develop effective strategies for optimizing their market position.